Largest pharmaceuticals by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Pfizer leads the 61 pharmaceuticals ranked by total assets, at PLN 838B, ahead of Johnson & Johnson (PLN 802B) and Sanofi (PLN 566.4B). Figures as of 18 Nov 2026, 16:15 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerPLN 838B
- Median
- PLN 14.2B
- Combined market value
- PLN 20.45T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | PLN 838B | PLN 645.9B | PLN 113.32 | 1.12% down | 14% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | PLN 802B | PLN 2.67T | PLN 1,107.59 | 1.28% down | 38% up | ||
| 3 | SanofiSNY · Health Care | PLN 566.4B | PLN 457.2B | PLN 190.40 | 0.49% down | 4% down | ||
| 4 | Merck & CoMRK · Health Care | PLN 551B | PLN 1.38T | PLN 561.52 | 2.71% down | 51% up | ||
| 5 | AbbVieABBV · Health Care | PLN 539.3B | PLN 2.05T | PLN 1,160.24 | 1.57% down | 26% up | ||
| 6 | AstraZenecaAZN · Health Care | PLN 459.2B | PLN 1.12T | PLN 719.37 | 1.96% down | 2% up | ||
| 7 | Eli LillyLLY · Health Care | PLN 452.8B | PLN 4.98T | PLN 5,587.96 | 1.94% down | 35% up | ||
| 8 | NovartisNVS · Health Care | PLN 446.6B | PLN 1.19T | PLN 628.49 | 1.89% down | 25% up | ||
| 9 | Takeda PharmaceuticalTAK · Health Care | PLN 391.1B | PLN 274.7B | PLN 85.99 | 1.29% down | 54% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | PLN 362.5B | PLN 493.4B | PLN 241.38 | 2.27% down | 34% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | PLN 349.1B | PLN 726.3B | PLN 419.36 | 0.52% down | 17% down | ||
| 12 | GSKGSK · Health Care | PLN 326.6B | PLN 393.5B | PLN 196.29 | 0.97% down | 6% up | ||
| 13 | Novo NordiskNVO · Health Care | PLN 324.3B | PLN 703.8B | PLN 159.69 | 2.54% down | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | PLN 164B | PLN 198.5B | PLN 170.09 | 0.87% down | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | PLN 163.3B | PLN 397.4B | PLN 3,841.88 | 0.36% down | 36% up | ||
| 16 | ViatrisVTRS · Health Care | PLN 149.7B | PLN 95.3B | PLN 83.15 | 1.00% up | 96% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | PLN 103.2B | PLN 544.6B | PLN 2,147.99 | 0.12% down | 27% up | ||
| 18 | GrifolsGRFS · Health Care | PLN 88B | PLN 23.4B | PLN 34.36 | 1.10% down | 1% up | ||
| 19 | Royalty PharmaRPRX · Health Care | PLN 79B | PLN 158.4B | PLN 275.52 | 0.35% down | 78% up | ||
| 20 | ZoetisZTS · Health Care | PLN 62.3B | PLN 137B | PLN 337.13 | 0.32% up | 29% down | ||
| 21 | Elanco Animal HealthELAN · Health Care | PLN 53.8B | PLN 53.1B | PLN 106.14 | 1.99% up | 20% up | ||
| 22 | GenmabGMAB · Health Care | PLN 51.8B | PLN 127.4B | PLN 206.60 | 1.23% down | 70% up | ||
| 23 | Jazz PharmaceuticalsJAZZ · Health Care | PLN 46.9B | PLN 62.9B | PLN 980.36 | 1.17% up | 37% up | ||
| 24 | BeOne MedicinesONC · Health Care | PLN 33B | PLN 185.7B | PLN 1,625.53 | 2.29% down | 17% up | ||
| 25 | United TherapeuticsUTHR · Health Care | PLN 31.7B | PLN 98.5B | PLN 2,313.97 | 1.59% down | 23% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | PLN 30.6B | PLN 46.7B | PLN 241.10 | 2.36% up | 11% up | ||
| 27 | Dr. Reddy's LaboratoriesRDY · Health Care | PLN 24.8B | PLN 50.2B | PLN 60.27 | 1.23% up | 5% up | ||
| 28 | Roivant SciencesROIV · Health Care | PLN 23B | PLN 113B | PLN 156.00 | 0.10% up | 90% up | ||
| 29 | Alnylam PharmaceuticalsALNY · Health Care | PLN 20B | PLN 82.4B | PLN 615.49 | 2.31% down | 66% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | PLN 14.8B | PLN 30.2B | PLN 86.67 | 1.94% up | 83% up | ||
| 31 | Ionis PharmaceuticalsIONS · Health Care | PLN 14.2B | PLN 18.3B | PLN 110.00 | 1.35% up | 64% down | ||
| 32 | PTC TherapeuticsPTCT · Health Care | PLN 11.7B | PLN 20.3B | PLN 242.83 | 0.07% down | 20% down | ||
| 33 | AlkermesALKS · Health Care | PLN 10B | PLN 31.5B | PLN 187.64 | 2.55% up | 58% up | ||
| 34 | InsmedINSM · Health Care | PLN 9.1B | PLN 106B | PLN 483.10 | 1.52% down | 40% down | ||
| 35 | Legend BiotechLEGN · Health Care | PLN 7B | PLN 12.7B | PLN 65.38 | 0.81% up | 42% down | ||
| 36 | Ligand PharmaceuticalsLGND · Health Care | PLN 6.3B | PLN 24.1B | PLN 1,205.21 | 1.90% up | 43% up | ||
| 37 | Ascendis PharmaASND · Health Care | PLN 5.8B | PLN 71.2B | PLN 1,085.92 | 0.53% down | 28% up | ||
| 38 | CytokineticsCYTK · Health Care | PLN 5.7B | PLN 28.7B | PLN 205.95 | 0.95% down | 20% down | ||
| 39 | Arrowhead PharmaceuticalsARWR · Health Care | PLN 5.6B | PLN 24.6B | PLN 174.31 | 0.72% up | 10% up | ||
| 40 | Madrigal PharmaceuticalsMDGL · Health Care | PLN 5.1B | PLN 38.3B | PLN 1,649.69 | 2.89% down | 24% down | ||
| 41 | TG TherapeuticsTGTX · Health Care | PLN 4.3B | PLN 39.3B | PLN 259.84 | 2.93% up | 107% up | ||
| 42 | Praxis Precision MedicinesPRAX · Health Care | PLN 3.8B | PLN 34.3B | PLN 1,226.59 | 0.12% down | 61% up | ||
| 43 | Cogent BiosciencesCOGT · Health Care | PLN 3.8B | PLN 19.9B | PLN 114.35 | 1.99% up | 20% down | ||
| 44 | BridgeBio PharmaBBIO · Health Care | PLN 3.8B | PLN 60.8B | PLN 312.35 | 1.03% up | 17% up | ||
| 45 | Mirum PharmaceuticalsMIRM · Health Care | PLN 3.4B | PLN 23.9B | PLN 366.66 | 0.95% down | 31% up | ||
| 46 | Corcept TherapeuticsCORT · Health Care | PLN 3.4B | PLN 30.1B | PLN 274.79 | 2.58% down | 8% down | ||
| 47 | Belite BioBLTE · Health Care | PLN 3.1B | PLN 26B | PLN 640.73 | 0.91% up | 31% up | ||
| 48 | Spyre TherapeuticsSYRE · Health Care | PLN 3.1B | PLN 36.4B | PLN 383.21 | 1.47% up | 286% up | ||
| 49 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | PLN 3.1B | PLN 30.4B | PLN 386.87 | 1.04% up | 126% up | ||
| 50 | Summit TherapeuticsSMMT · Health Care | PLN 3B | PLN 34.5B | PLN 43.10 | 0.33% up | 36% down | ||
| 51 | Axsome TherapeuticsAXSM · Health Care | PLN 2.8B | PLN 28.3B | PLN 537.23 | 1.84% down | 7% down | ||
| 52 | Protagonist TherapeuticsPTGX · Health Care | PLN 2.7B | PLN 32.7B | PLN 501.40 | 0.10% down | 46% up | ||
| 53 | ABIVAXABVX · Health Care | PLN 2.6B | PLN 29.5B | PLN 336.71 | 1.88% up | 27% down | ||
| 54 | Travere TherapeuticsTVTX · Health Care | PLN 2.4B | PLN 19.4B | PLN 202.33 | 1.64% down | 44% up | ||
| 55 | Edgewise TherapeuticsEWTX · Health Care | PLN 2.2B | PLN 18B | PLN 164.41 | 2.85% down | 88% up | ||
| 56 | Dianthus TherapeuticsDNTH · Health Care | PLN 2.1B | PLN 19.6B | PLN 347.74 | 0.69% down | 113% up | ||
| 57 | Oruka TherapeuticsORKA · Health Care | PLN 2B | PLN 26.4B | PLN 388.68 | 0.24% up | 241% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | PLN 1.9B | PLN 32.6B | PLN 469.80 | 0.08% up | 13% up | ||
| 59 | Definium TherapeuticsDFTX · Health Care | PLN 1.8B | PLN 15.7B | PLN 114.67 | 3.05% down | 169% up | ||
| 60 | ErascaERAS · Health Care | PLN 1.6B | PLN 18.7B | PLN 53.22 | 4.82% down | 403% up | ||
| 61 | VeradermicsMANE · Health Care | PLN 614.4M | PLN 21.1B | PLN 501.04 | 0.94% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0257 PLN).
Questions and answers
Which pharmaceuticals rank first by total assets?
Pfizer (PLN 838B), Johnson & Johnson (PLN 802B) and Sanofi (PLN 566.4B) are the top three of the 61 pharmaceuticals ranked by total assets as of 18 Nov 2026, 16:15 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by total assets.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by total assets have a combined market value of PLN 20.45T as of 18 Nov 2026, 16:15 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.